Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life SettingDaniele Di Carlo, Ombretta Turriziani, Enrico Palermo et al.|AIDS Research and Human Retroviruses|2021Cited by 11
Virus-like particle – mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infectionEnrico Palermo, John Hiscott|Frontiers in Cellular and Infection Microbiology|2022Cited by 9